Baker Avenue Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Baker Avenue Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,882	Closed	-$322K	–	670
2025 Q2	$322K	Buy	+3,882	New	+$310K	0.01%	369
2024 Q4	–	Sell	-3,467	Closed	-$343K	–	456
2024 Q3	$343K	Buy	+3,467	New	+$341K	0.01%	328
2023 Q4	–	Sell	-1,606	Closed	-$117K	–	1524
2023 Q3	$117K	Hold	1,606	–	–	0.01%	403
2023 Q2	$134K	Hold	1,606	–	–	0.01%	383
2023 Q1	$122K	Sell	1,606 -208	-11%	-$17.3K	0.01%	406
2022 Q4	$151K	Buy	+1,814	New	+$147K	0.01%	353
2021 Q4	–	Sell	-1,606	Closed	-$201K	–	313
2021 Q3	$201K	Hold	1,606	–	–	0.01%	254
2021 Q2	$217K	Hold	1,606	–	–	0.01%	228
2021 Q1	$217K	Sell	1,606 -4,053	-72%	-$607K	0.01%	228
2020 Q4	$796K	Buy	5,659 +44	+0.8%	+$5.64K	0.05%	142
2020 Q3	$625K	Sell	5,615 -3,912	-41%	-$439K	0.05%	151
2020 Q2	$1.07M	Sell	9,527 -1,023	-10%	-$101K	0.09%	119
2020 Q1	$816K	Sell	10,550 -3,560	-25%	-$315K	0.1%	87
2019 Q4	$1.34M	Sell	14,110 -4,926	-26%	-$426K	0.1%	130
2019 Q3	$1.45M	Sell	19,036 -566	-3%	-$47K	0.12%	113
2019 Q2	$1.72M	Sell	19,602 -3,093	-14%	-$264K	0.14%	102
2019 Q1	$2.05M	Buy	22,695 +1,187	+6%	+$101K	0.17%	92
2018 Q4	$1.54M	Sell	21,508 -3,067	-12%	-$247K	0.15%	104
2018 Q3	$2.36M	Sell	24,575 -160	-0.6%	-$15.5K	0.19%	91
2018 Q2	$2.35M	Buy	24,735 +63	+0.3%	+$5.79K	0.2%	90
2018 Q1	$2.16M	Sell	24,672 -2,149	-8%	-$196K	0.2%	91
2017 Q4	$2.28M	Buy	26,821 +5,135	+24%	+$430K	0.22%	88
2017 Q3	$1.88M	Sell	21,686 -2,420	-10%	-$194K	0.21%	86
2017 Q2	$1.86M	Sell	24,106 -1,469	-6%	-$104K	0.25%	79
2017 Q1	$1.77M	Sell	25,575 -2,325	-8%	-$156K	0.24%	75
2016 Q4	$1.65M	Sell	27,900 -8,336	-23%	-$515K	0.23%	77
2016 Q3	$2.4M	Buy	36,236 +9,415	+35%	+$582K	0.34%	72
2016 Q2	$1.45M	Sell	26,821 -6,880	-20%	-$377K	0.22%	86
2016 Q1	$1.74M	Buy	+33,701	New	+$1.75M	0.26%	69